New-generation Contract Development and Manufacturing Organization (CDMO) Amaran Biotech has been awarded the prestigious “Bioprocessing Excellence in Taiwan” honor at the Asia-Pacific Biopharma Excellence Awards 2025 ceremony, hosted by renowned consulting firm IMAPAC in Singapore on March 12.
Amaran Biotechnology Inc., a subsidiary of OBI Pharma specializing in Contract Development and Manufacturing Organization (CDMO) services for next-generation pharmaceuticals, announced today that it has signed a Memorandum of Understanding (MOU) with Nippon Fine Chemical Co., Ltd., and its Taiwan subsidiary, Zillion Fine Chemicals International Co., Ltd. The three parties aim to deepen collaboration in the field of nanoparticle-based drug CDMO manufacturing while expanding their presence in Taiwan, Japan, and international CDMO markets.
Amaran Biotech, through the close collaboration of its IT, Warehouse, and Quality Management (QM) departments, has successfully implemented a Warehouse Management System (WMS) developed by Unitech Electronics. This system enables fully digitized management for the warehouse operation and the DS and DP production lines of Amaran. As the core of manufacturing and supply chain operations, the WMS oversees the entire material management process—from raw materials to finished products—aiming to optimize product and material handling with high efficiency and low cost.